Related Content

View more
  • post image
    06/07/2024

    Advancing transcriptional cancer therapies with Tempus’ comprehensive life science solutions

    Kronos Bio, a trailblazer in the biopharmaceutical industry, is dedicated to the discovery and development of novel therapies that target transcriptional regulation in cancer. Kronos turned to Tempus’ comprehensive suite of solutions to propel its principal asset from discovery to clinical trials.

    LIVE WEBINAR

    Wednesday, July 31 @ 11am CT

    Integrating Omics in R&D: A new era of biomedical research

    Join us as we explore how multi-omics is reshaping the research landscape. Gain valuable insights from industry leaders as we: dive into the integration of diverse omics data, from NGS to proteomics, in research; discuss the transformative role of multi-omics in understanding complex disease mechanisms; and explore how multi-omics is personalizing clinical research for precision medicine.

    Read more
  • post image
    05/30/2024

    Accelerating ADC Development with Tempus AI

    Empowering precision and efficiency in ADC therapeutics with advanced data analytics

    Read more
  • post image
    05/14/2024

    Using AI to identify and close gaps in care for cancer patients

    Learn how Tempus Next is helping clinicians close gaps in care for patients with cancer.

    Watch replay